Cite
HARVARD Citation
Absalon, J. et al. (2021). Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial. Lancet infectious diseases. 21 (2), pp. 263-274. [Online].